Evidence map›Paper›PMID 19624684›Full record

ArticleCell proliferation2009

Hybrid mathematical model of glioma progression.

M L Tanaka, W Debinski, I K Puri

Abstract read
In one paragraph

Article in Cell proliferation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A mathematical model of pre-diagnostic glioma growth.Journal of theoretical biology · 2015
    Article
  10. Article
  11. Article
  12. Article
  13. Computer implementation of a new therapeutic model for GBM tumor.Computational and mathematical methods in medicine · 2014
    Article
  14. Mathematical modelling of spatio-temporal glioma evolution.Theoretical biology & medical modelling · 2013
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M L TanakaDepartment of Orthopaedic Surgery, Wake Forest University, Winston-Salem, North Carolina, USA.
W Debinski
I K Puri

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesGliomas are an important form of brain cancer, with high mortality rate. Mathematical models are often used to understand and predict their behaviour. However, using current modeling techniques one must choose between simulating individual cell behaviour and modeling tumours of clinically significant size. MATERIALS AND

methodsWe propose a hybrid compartment-continuum-discrete model to simulate glioma growth and malignant cell invasion. The discrete portion of the model is capable of capturing intercellular interactions, including cell migration, intercellular communication, spatial cell population heterogeneity, phenotype differentiation, epigenetic events, proliferation, and apoptosis. Combining this with a compartment and continuum model allows clinically significant tumour sizes to be evaluated. RESULTS AND

conclusionsThis model is used to perform multiple simulations to determine sensitivity to changes in important model parameters, specifically, the fundamental length parameter, necrotic cell degradation rate, rate of cell migration, and rate of phenotype transformation. Using these values, the model is able to simulate tumour growth and invasion behaviour, observed clinically. This mathematical model provides a means to simulate various tumour development scenarios, which may lead to a better understanding of how altering fundamental parameters can influence neoplastic progression.

Indexed as

Models, BiologicalBrain NeoplasmsCell CommunicationCell DifferentiationCell DivisionCell MovementComputer SimulationGliomaHumansNecrosisNeoplasm InvasivenessNeovascularization, PathologicStochastic Processes

Identifiers

PMID19624684
PMCPMC6496370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.